SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following constructive discussions with the FDA regarding a resubmission path for ANKTIVA in bladder cancer, complemented by significant international approvals and strategic partnerships like those recently established in Saudi Arabia for broader cancer indications. This development, coupled with high short interest, is fueling widespread community excitement about a potential paradigm shift in oncology and intense speculation regarding a short squeeze amidst growing calls for expedited access to these innovative treatments.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending as market participants react to heightened geopolitical tensions, specifically former President Trump's recent tariff threats against NATO allies over Greenland and an anticipated Supreme Court ruling on presidential tariff authority. This has sparked a fierce debate among investors, with some advocating to "buy the dip" and anticipating a rapid "Taco Trade" rebound, while others warn of a significant market correction. Adding to the volatility are concerns surrounding Japan's bond market instability, creating a complex and uncertain trading environment.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending after announcing a non-exclusive license agreement with Pfizer for its Matrix-M adjuvant, providing significant validation for the technology. This deal, building on previous collaborations, is driving community excitement and fueling discussions about the adjuvant's potential applications and the company's future partnerships amidst notable short interest.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as former President Trump's renewed threats of tariffs on NATO allies, particularly over the acquisition of Greenland, spark fears of a trade war with Europe. This escalating geopolitical tension is causing widespread market jitters and calls for caution, though many investors are also discussing it as a potential "buy the dip" opportunity for growth stocks.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is currently a major talking point among investors, primarily driven by its upcoming earnings report and the proposed all-cash acquisition of Warner Bros. Discovery assets, which has sparked a debate over potential growth versus debt concerns. The community is closely watching for strong ad-tier performance and subscriber metrics, particularly after a previous tax-related earnings miss, with sentiment split on whether recent oversold conditions signal a significant rebound or continued volatility.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending amid intense debate surrounding the Federal Reserve's independence, fueled by a federal probe into its Chair and the administration's aggressive policy maneuvers impacting bond markets. Investors are actively discussing whether long-term treasuries offer a crucial hedge against a potential economic slowdown or face further headwinds from escalating national debt and geopolitical uncertainty.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending after announcing positive data from its placebo-controlled Phase 1 clinical trial of soquelitinib for atopic dermatitis, showing strong efficacy. The community is actively discussing the oral ITK inhibitor's potential in a large market, with many anticipating significant revaluation and partnership opportunities for its novel mechanism of action.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin (APP) is actively trending amid recent allegations of money laundering and illicit financial ties, triggering a sharp sell-off across the stock. Despite this, community sentiment is divided, with many dismissing the claims as a coordinated short attack ahead of strong earnings, while others are seizing the opportunity to buy into the fundamentally strong AI-powered ad platform.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares ETF (GLD) is trending strongly as renewed geopolitical tensions, including recent tariff threats concerning European countries over Greenland, fuel a broad flight to safety. The community views gold as a crucial hedge against eroding fiat currency confidence and economic instability, driving prices to consistent new highs. Many are discussing significant further appreciation as these global uncertainties persist.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is seeing heightened conversation due to recent developments surrounding Trump's assertive stance on Greenland and reactions to a perceived Nobel Peace Prize snub, which has sparked discussions of new tariffs on European nations. The community is actively debating the potential for increased market volatility, geopolitical instability, and the broader economic ramifications of these actions. This ongoing dialogue underscores intense political polarization and its influence on market sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MIAMI, May 21, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 82nd Emerging Growth Conference on May 21 &amp; 22, 2025.The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products &amp; services, focused strategy, execution, and the overall potential for long-term growth.<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=EbOWqh8i53PXrwNlmG0Wlv_ppcrooXY9gGGN-pmvbQsHP9Dy9zxKHcxPfUjl1q9Ecxa3oyi1-6Ovay6xvfn789unux0OcG0fqP_asO9e3CSXIFflEvbbHEkkqhRcCSyZYh8ZDddVtPCT0D5HIszqDqu1Zm4NKA3cpuaDrKAlBbQ4jYP9aV7Nt1jPY1i_I9gI">Register for the Conference here.</a>Submit Questions for any of the presenting companies to:&nbsp; <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=kVS7sRiC5r3pmKmmLmcnFfKVHwn3ForBjHdEL_DkjcAdSa7Vfl49Vmps4dZXZnR3R1AllwAIK6zplkM63tKkp1bl6U36BmbuKFnRAn9_bd0bE6Eoh-CVgzqqSw0wBQP7">Questions@EmergingGrowth.com</a>For updates, <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=QyoNQ3EHdryQlOSsMA6n-naij0y67SP9RKqot4s4-sGqcJevbJZfdMFD3-e24k-Bq0SWVBj1RsK7zMrMYt3PEW5x_B9Mu003Ab1rFrMgkKbuA-WGNCZdEJAvfT-JhRBa">follow us on Twitter</a>Day 1 – Presenting Today, May 21, 20258:45 Virtual Lobby opens. <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=EbOWqh8i53PXrwNlmG0Wlv_ppcrooXY9gGGN-pmvbQsCtCEaOWn5mCiO23xzl5Xj94vjJcI0-QljrHizBLlj5RRBSojDiBqMUAAO43qk4UXYQe2rCcfn2q0zt869_6p6zBXqnVRmTt8JBiM0bPtfa1DtQ9--5ogE1sPyxzN9U4OLTe4JVo5Hn0STsOKOC5o0">Register for the Conference.</a>&nbsp;If you already registered, go back to the registration link and click “Already registered” and enter your email.9:00 Introduction9:05 – 9:35 Aurora Mobile Limited (NASDAQ: JG) Keynote speaker: Shan-Nen Bong, CFOPostponed to June 17 ASP Isotopes Inc. (NASDAQ: ASPI) Keynote speaker: Paul Elliot Mann, CEO10:15 – 10:45 HeartSciences, Inc. (NASDAQ: HSCS)&nbsp; Keynote speaker: Andrew Simpson, President / CEO11:25 - 11:55 Thumzup Media Corporation (NASDAQ: TZUP) Keynote speaker: Robert Steele, CEO12:00 – 12:30 22nd Century Group, Inc. (NASDAQ: XXII) Keynote speaker: Lawrence D. Firestone, Chairman &amp; CEO1:10 – 1:40 Medicenna Therapeutics Corp. (OTCQX: MDNAF) (TSX: MDNA) Keynote speaker: Fahar Merchant, President and CEOPostponed to June Conference Sono Group N.V. (OTCQB: SEVCF) Keynote speaker: George O’Leary, Managing Director, CEO and CFO2:55 – 3:05 NCS Multistage Holdings, Inc. (NASDAQ: NCSM) Keynote speaker: Ryan Hummer, CEO &amp; Director3:10 - 3:20 Clene Inc., (NASDAQ: CLNN) Keynote speakers: Rob Etherington, President / CEO3:25 - 3:35 Interstellar Communication Holdings Keynote speakers: Seda Hewitt, Space Ambassador of IcMercury Harri Laitinen, Lifeguard of IcMercury, and Lijie Zhu, Captain of IcMercury3:40 – 3:50 Touchstone Explorations, Inc. (OTC Pink: PBEGF) (TSX: TXP) Keynote speaker: Paul Raymond Baay, President &amp; CEO4:10 – 4:20 Citizens, Inc. (NYSE: CIA) Keynote speakers: Jon Stenberg, President / CEO, and Jeff Conklin, CFO4:25 - 4:35 MetaVia, Inc. (NASDAQ: MTVA) Keynote speakers: Hyung Heon “HH” Kim, President / CEO, &amp; Marshall H. Woodworth, CFO _______________________________________________________________Day 2 – Presenting Tomorrow, May 22, 20258:45 Virtual Lobby opens. <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=EbOWqh8i53PXrwNlmG0Wlv_ppcrooXY9gGGN-pmvbQu7PXLRYq49yKICWecEGDrFt2jSl2mK6BAJbvHIayyZIvCsoKppGsv7tyFtfFK6sa6v2JLC-iMB27xVDvue-fZ7Olg3FVgJlhrNLEvIgGsmmuC2kOrAG-TFl8R9lX8qNXH0gQZjb6wdmmXG8OD8hWw-">Register for the Conference.</a>&nbsp;If you already registered, go back to the registration link and click “Already registered” and enter your email.9:00 Introduction9:05 – 9:35 TNL Mediagene’s (NASDAQ: TNMG)&nbsp; Keynote speaker: Joey Chung, Co-Founder &amp; CEOPostponed to the June Conference Jaguar Health, Inc. (NASDAQ: JAGX) Keynote speaker: Lisa A. Conte, Founder, CEO, President &amp; Director10:15 – 10:45 Onfolio Holdings, Inc. (NASDAQ: ONFO) Keynote speaker: Dominic Wells, CEO10:50 – 11:20 Rackla Metals Inc. (OTC Pink: RMETF) (TSX-V: RAK) Keynote speaker: Simon T. P. Ridgway, Chairman &amp; CEO11:25 – 11:35 Bioxytran, Inc. (OTCQB: BIXT) Keynote speakers: Dr. David Platt, CEO &amp; Mike Sheikh, Executive Vice President Business Development12:00 – 12:30 AtlasClear Holdings, Inc. (NYSE: ATCH)&nbsp; Keynote speakers: Craig Ridenhour, President &amp; John Schaible, Chairman and CEO12:35 – 1:05 Faraday Future Intelligent Electric, Inc. (NASDAQ: FFAI) Keynote speakers: Jerry Wang, Global President1:10 – 1:40 Vizsla Royalties Corp. (TSXV: VROY) (OTCQB: VROYF) Keynote speaker: Michael N. Pettingell, President and CEO1:45 - 2:15 Wytec International, Inc. (OTCQB: WYTC) Keynote speaker: William Gray, CEO, CFO2:20 – 2:50 Zyppah Keynote speaker: Dr. Jonathan Greenburg, founder and owner, &amp; Larry Biggs, CEO2:55 – 3:05 Ucore Rare Metals, Inc. (OTCQX: UURAF) (TSXV: UCU) Keynote speakers: Pat Ryan, CEO3:10 - 3:20 Regen BioPharma Inc. (OTC Pink: RGBP) Keynote speakers: David Koos, President / CEO, &amp; Harry M. Lander, Ph.D. Senior Scientific Consultant3:25 – 3:35 Monumental Energy Corp. (OTCQB: MNMRF) (TSXV: MNRG) Keynote speaker: Maximilian Sali, VP Corporate Development, Founder &amp; Director3:40 – 3:50 HydroGraph Clean Power Inc. (OTCQB: HGRAF) (CSE: HG) Keynote speaker: Kjirstin Breure, President and CEO3:55 – 4:05 West Red Lake Gold Mines Ltd. (OTCQB: WRLGF) (TSXV: WRLG) Keynote Speaker: Gwen Preston, Vice President, Communications4:10 – 4:20 XBP Europe Holdings, Inc. (NASDAQ: XBP)&nbsp; Keynote speaker: Andrej Jonovic, CEO &amp; Director4:25 – 4:35 Gossamer Bio, Inc. (NASDAQ: GOSS) Keynote speaker: Bryan Giraudo, CFO &amp; COO4:40 – 4:50 Highland Copper Company Inc. (OTCQB: HDRSF) (TSXV: HI) Keynote speaker: Barry O’Shea, CEOVisit the following link to register. You will then receive an email containing the link and time to sign into the conference.<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=EbOWqh8i53PXrwNlmG0Wlv_ppcrooXY9gGGN-pmvbQticY_xllLbbXDdJzBnThtCgpzeG1RreUN9uOWWzEzGFDrv_EioYkwLh3YKkit05u_zoeukNoAon6bIDsEg59jdviZArnXg17V9qHcd-NwkSN1H3Ck8RNMJitlywH2ewmi2dUe_513vxvnzu8nZgVoH">Register for the Conference here.</a>Submit Questions for any of the presenting companies to:&nbsp; <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=kVS7sRiC5r3pmKmmLmcnFfKVHwn3ForBjHdEL_DkjcCXWt1jEcdouclrAjUDONNi0vjFTY2TzEicQe757ZBgD4zn4aIBRFrMSpQVCfPE9U8-k3_hxxQu7O-FCtuf3pYz">Questions@EmergingGrowth.com</a>Replays: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=z2Fwu4AR6GcKiqmUvMmGxOvS5RTh-ZTPtR1p5DdIsuIwVjZ85Xoj6Os0MZbBcOSPqn0U9BXgLipCq376rJX0i-AO7CPfsFFyky-Hcw64TQAsdxfFrbB_pKw2gTc7xeqGm-2ZWxk62kK2wGlgLna1oA==">Subscribe to our YouTube Channel</a>About&nbsp;EmergingGrowth.comFounded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.About the Emerging Growth ConferenceThe Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=GQlkz4IPN52hqcN02CUC-y8Tp54nzgA0ovKGjy1JW3GrXlwtcyD0IGmti_UZw_LBQDX-MyrQ-PpCsSJ0rXrbQ49Sl6Q1-eNMU6DTfywB5UE=">EmergingGrowth.com</a>&nbsp;nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.If you believe or know of a company that might fit our audience, <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=biswmavP_w1VMp7Nel7C9D9j1OHwXxFTRybukMNLw3mfp4cLnXEu-KESeF_4-WRfBO2XC9shr8k4h19cKN_PORMM2bC-lqUOhSwmxLe3qv1jkbu7osyk3VYR6BQGYSRF">contact us here.</a>Thank you for your interest in our conference, and we look forward to your participation in future conferences.Contact:Emerging Growth&nbsp; Phone: 1-305-330-1985 Email: Conference@EmergingGrowth.com

Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream

Others

BioXyTran, Inc. engages in the development, manufacture, and commercialization of therapeutic drugs designed to address hypoxia in humans, which is a lack of oxygen in tissues. Its product pipeline includes BXT-25, a drug designed to oxygenate ischemic (reduced blood flow) regions in the brain that suffered from hypoxia during a brain stroke, and BXT-252, which treats chronic wounds resulting from ischemia caused by occlusion of capillaries. The company was founded on June 9, 2008 and is headquartered in Needham, MA.

Current Price	$0.0654
Prev Close	$0.0662
Open	$0.065
Dividend Yield	0.00%
50-Day Moving Average	$0.0737
Beta	0.31
Avg. Volume	147,766.00
PE Ratio	-2.73

52-Week High	$0.2283
52-Week Low	$0.0391
Market Capitalization	$6.46M
EPS (Annual)	-$0.0171
Price to Book	-1.97
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

BIXT
Bioxytran Inc

Feed

News

Sentiment

Fundamentals

Info

Latest BIXT News

BIXTBioxytran Inc